Form 4 holding
Chief Operating Officer
Indaptus Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 54,426
- Estimated value
- $110,484
- Report date
- 22 Dec 2025
- Price
- $2.03
- Ownership
- Direct
Walt Addison Linscott
Insider Reports History
- Reporting-owner location
- Tucker, GA
- Latest reporting-owner signature
-
/s/ Walt Linscott
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Walt Addison Linscott
Form 4 holding
Chief Operating Officer
Indaptus Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 10 Apr 2025
- Price
- $0.0590
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Walt Addison Linscott
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 22 Dec 2025
- Transactions
- 1
- Transaction value
- +$110,475
- Accepted by SEC
- 29 Dec 2025, 16:01
- Role
- Chief Operating Officer
- Next action
- Open filing details
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 10 Apr 2025
- Transactions
- 6
- Transaction value
- -$502
- Accepted by SEC
- 11 Apr 2025, 16:15
- Role
- Chief Operating Officer
- Next action
- Open filing details
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 09 Oct 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 10 Oct 2024, 16:05
- Role
- Chief Operating Officer
- Next action
- Open filing details
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 22 Jan 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 23 Jan 2024, 16:15
- Role
- Chief Operating Officer
- Next action
- Open filing details
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 18 Jan 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 20 Jan 2023, 15:05
- Role
- Chief Business Officer
- Next action
- Open filing details
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 07 Sep 2022
- Transactions
- 1
- Transaction value
- +$393
- Accepted by SEC
- 09 Sep 2022, 09:00
- Role
- Chief Business Officer
- Next action
- Open filing details
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 26 Jan 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 28 Jan 2022, 15:30
- Role
- Chief Business Officer
- Next action
- Open filing details
4
INDP
Indaptus Therapeutics, Inc.
- Report period
- 04 Aug 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 06 Aug 2021, 17:00
- Role
- Chief Business Officer
- Next action
- Open filing details
3
INDP
Intec Parent Inc.
- Report period
- 23 Jul 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 02 Aug 2021, 16:45
- Role
- Chief Business Officer
- Next action
- Open filing details